文献速递前列腺增生与排尿功能障碍

糖尿病、糖尿病严重程度、糖尿病生物标志物与下尿路症状存在的关系:来自美国国家健康与营养调查的发现

The Relationship Between Diabetes, Diabetes Severity, Diabetes Biomarkers, and the Presence of Lower Urinary Tract Symptoms: Findings From the National Health and Nutrition Examination Survey.
PubMed 文献 · Urology · 2017-04-06

该研究基于2005—2008年美国国家健康与营养调查中完成糖尿病及肾脏/前列腺问卷的2127名男性,评估糖尿病与下尿路症状的关联。患有糖尿病(n=405)的男性报告至少1项泌尿症状的调整比值比为1.63(P<.0001)。糖尿病特异性生物标志物(糖化血红蛋白、空腹血糖)不能预测下尿路症状,而间接反映疾病进展的标志物最有用。

要点

  • 糖尿病患者(n=405)较无糖尿病者更易报告至少1项下尿路症状,调整比值比为1.63(P<.0001)。
  • 70岁以下且糖尿病病程超过5年的男性,比病程少于5年者更易报告下尿路症状。
  • 在积极治疗的糖尿病患者中,糖化血红蛋白和空腹血糖不能预测下尿路症状。

核心结论

  • 糖尿病与男性患者报告的下尿路症状强烈相关。
  • 较年轻男性和病程较长的男性似乎最易感。
  • 在积极治疗的糖尿病患者中,糖尿病生物标志物对预测个体下尿路症状无帮助,而间接反映糖尿病疾病进展的生物标志物最有用。

研究设计与样本

  • 查询2005—2008年周期美国国家健康与营养调查中完成糖尿病和肾脏/前列腺问卷的男性。
  • 下尿路症状定义为经历夜尿、排尿踌躇或排空不全3项中至少1项。
  • 糖尿病定义为由医生诊断并正在积极治疗。
  • 采用样本加权的多因素logistic回归评估生物标志物水平(糖化血红蛋白、空腹血糖)、药物使用和疾病进展替代指标对下尿路症状存在的影响。
  • 共纳入2127名男性参与者,其中糖尿病患者405例。

主要发现

  • 糖尿病患者(n=405)更可能经历至少1项泌尿症状,调整比值比为1.63(P<.0001)。
  • 70岁以下且糖尿病病程超过5年的男性,比病程少于5年者更可能报告下尿路症状。
  • 糖尿病特异性生物标志物(糖化血红蛋白、空腹血糖)在糖尿病患者中不是下尿路症状的预测因素。

关键数值与推荐

  • 下尿路症状定义:夜尿、排尿踌躇或排空不全3项中至少1项。
  • 糖尿病定义:由医生诊断并正在积极治疗。
  • 糖尿病与至少1项泌尿症状的调整比值比为1.63(P<.0001)。
  • 长病程定义为糖尿病病程超过5年,短病程定义为少于5年。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To characterize the associations between diabetes mellitus (DM) and lower urinary tract symptoms (LUTS). This study focuses on the relationships between specific diabetic characteristics (eg, severity, biomarkers) and the prevalence of LUTS. MATERIALS AND METHODS: The 2005-2008 cycles of the National Health and Nutrition Examination Survey were queried for men who completed both a DM and a kidney/prostate questionnaire. Men with LUTS were defined as those experiencing at least 1 out of 3 of the following: nocturia, hesitancy, or incomplete emptying. Men with DM were defined as having been diagnosed by a physician and being actively treated. Multivariate logistic regression with sample weighting was performed to assess effects of biomarker levels (HgbA1c, fasting glucose), medication use, and surrogates of disease progression on the presence of LUTS. RESULTS: Of the 2127 male participants, those with DM (n = 405) were more likely to experience at least 1 urinary symptom (adjusted odds ratio 1.63, P <.0001). Men under the age of 70 with long-standing (>5 years) DM were more likely to report LUTS than those with a shorter duration of the disease (<5 years). Diabetes-specific biomarkers (HgbA1c, fasting glucose) were not predictors of LUTS in men with DM. CONCLUSION: DM was confirmed to be strongly associated with patient-reported LUTS in men. Younger men and those with longer-standing disease appear to be most susceptible. In actively treated patients with DM, DM biomarkers were not helpful in predicting individual LUTS. Instead, biomarkers that indirectly reflect DM disease progression were most useful.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Tam CA, Helfand BT, Erickson BA, et al. The Relationship Between Diabetes, Diabetes Severity, Diabetes Biomarkers, and the Presence of Lower Urinary Tract Symptoms: Findings From the National Health and Nutrition Examination Survey. Urology. 2017. PMID: 28392180. doi:10.1016/j.urology.2017.03.040

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。